Hawryluk P. Kent

CIK 0001673991

President & CEODirector

Filings

Latest May 8, 2026

Issuers covered

Showing

9 of 9

Page 1

Track record

3 of 4 open-market trades scored (75% price coverage) - 1 issuer without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).

Horizon	Trades	Win rate	Avg	Median	Best	Worst
30 days	3	67%	+34.5%	+17.2%	+92.5%	-6.1%
90 days	2	100%	+106.8%	+106.8%	+203.2%	+10.4%
180 days	2	100%	+76.1%	+76.1%	+137.4%	+14.7%
365 days	1	100%	+251.1%	+251.1%	+251.1%	+251.1%

Issuers

Companies where Hawryluk P. Kent has filed

Ticker	Issuer	Filings	Last filed
MBX	Mbx Biosciences, Inc.	9	May 8, 2026

All filings

9 Form 4 / 4-A filings, newest first

Filed	Issuer	Top transaction	Shares	Price	Value
May 8, 2026	MBXMbx Biosciences, Inc.	SSale	607	$29.54	$17,931
Mar 16, 2026	MBXMbx Biosciences, Inc.	PPurchase	18,500	$28.4142	$525,663
Feb 27, 2026	MBXMbx Biosciences, Inc.	MExercise	28,768	$16.00	$460,288
Feb 3, 2026	MBXMbx Biosciences, Inc.	AGrant	35,250	$0.00	$0
Oct 28, 2025	MBXMbx Biosciences, Inc.	MExercise	182,859	$3.25	$594,292
Oct 21, 2025	MBXMbx Biosciences, Inc.	PPurchase	20,000	$13.6395	$272,790
Feb 5, 2025	MBXMbx Biosciences, Inc.	PPurchase	50,000	$10.69	$534,500
Sep 17, 2024	MBXMbx Biosciences, Inc.	CConversion	283,846	-	-
Sep 13, 2024	MBXMbx Biosciences, Inc.	Holdings only	-	-	-

Showing 1-9 of 9

Page 1 of 1

Real-time Form 4 intelligence. Smarter insider tracking.

Filed		Top transaction	Shares	Price	Value